BioSpace News Archive

According to Vision Research Reports, the global artificial intelligence in medical imaging market is projected to grow at a CAGR of 36% during the forecast period 2022 to 2030 and to reach valuation of USD 20.1 billion by 2030.

Calithera Biosciences, Inc. (Nasdaq: CALA), announced that the first patient has been enrolled in a multicenter phase 2 clinical trial evaluating its spleen tyrosine kinase (SYK) inhibitor mivavotinib (CB-659) in patients with relapsed/refractory non-germinal center B-cell like (non-GCB) diffuse large B-cell lymphoma (DLBCL), a DLBCL subpopulation that primarily comprises patients with activated B-cell like disease (ABC).

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on SRP-5051 (vesleteplirsen), the Company’s next-generation peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) to treat patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping.

Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022.

Novavax, Inc. (Nasdaq: NVAX), today announced that the Taiwan Food and Drug Administration has granted emergency use authorization (EUA) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine in individuals aged 18 years and over.

According to Vision Research Reports, the global healthcare staffing market size is expected to be worth around US$ 50 billion by 2030 from valued at US$ 33 billion in 2021 and is anticipated to grow at a CAGR of 5.5% during forecast period 2022 to 2030.

As per Vision Research Reports, the global life sciences BPO market size surpassed at US$ 370 billion in 2021 and is expected to surpass around US$ 850 billion by 2030 with a registered CAGR of 12% from 2022 to 2030.

BioSig Technologies, Inc., a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced that it intends to offer shares of its common stock in a “best efforts” underwritten public offering.

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Habib Dable to its board of directors.

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing niche generic products, announced that it would release its 2022 year-end financial results on Wednesday, June 29, 2022.